EX-5 3 f81260ex5.txt EXHIBIT 5 EXHIBIT 5 Genentech, Inc. 1 DNA Way South San Francisco, California 94080 April 26, 2002 Ladies and Gentlemen: I am Senior Vice President, General Counsel and Secretary of Genentech, Inc. (the "Company"). In connection with this opinion, I have examined the following documents: - the Company's Registration Statement on Form S-8 (the "Registration Statement") to be filed with the Securities and Exchange Commission covering the offering of 15,000,000 shares of the Company's Common Stock, par value $.02 per share (the "Shares"), pursuant to the Company's 1999 Stock Plan, as amended and restated on December 8, 2000 (the "Plan") and the related Prospectus; - the Company's Amended and Restated Certificate of Incorporation and Bylaws; and - such other documents, records, certificates, memoranda and other instruments as I deem necessary as a basis for this opinion. I have assumed the genuineness and authenticity of all documents submitted to me as originals, the conformity to originals of all documents submitted to me as copies thereof, and the due execution and delivery of all documents where due execution and delivery are a prerequisite to the effectiveness thereof. On the basis of the foregoing, and in reliance thereon, I am of the opinion that the Shares, when sold and issued in accordance with the Registration Statement and the Plan and the related Prospectus, will be validly issued, fully paid, and nonassessable. I am admitted to practice only in the State of California. The opinions set forth herein are limited to matters of the General Corporation Law of Delaware and the federal securities laws of the United States. I consent to the filing of this opinion as an exhibit to the Registration Statement. Very truly yours, /s/ STEPHEN G. JUELSGAARD Stephen G. Juelsgaard Senior Vice President, General Counsel and Secretary